The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
Source: Italian Journal of Pediatrics
DPH2 is a biomarker associated with cell death, immunity and prognosis based on pan-cancer analysis
Source: Discover Oncology
Pattern of Orbito-ocular Tumours in Nigeria: a systematic review
Source: BMC Cancer
NXP032 Improves Memory Impairment Through Suppression of Tauopathy in PS19 Mice and Attenuates Okadaic Acid-Induced Tauopathy in SH-SY5Y Cells
Source: Journal of Neuroimmune Pharmacology
Medical management of cerebellar mutism syndrome at a quaternary children’s hospital
Source: Child's Nervous System
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
